Skip to content

A study to understand if there is deficiency of vitamin B 12 and increase in homocystiene in patients with stroke

A cross sectional study to evaluate serum Vitamin B12, homocystiene and hematological parameters in ischemic stroke patients at a tertiary care centre

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/03/024110
Enrollment
80
Registered
2020-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I639- Cerebral infarction, unspecified

Interventions

None listed

Sponsors

Chettinad hospital and research institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with ischemic stroke and transient ischemic attack

Exclusion criteria

Exclusion criteria: Patients with history of vitamin B12 deficiency Patients with history of hyperhomocysteinemia Patients with hemorrhagic stroke

Design outcomes

Primary

MeasureTime frame
Vitamin B 12 may administered to people with deficiency to prevent ischemic strokeTimepoint: 1year

Secondary

MeasureTime frame
Vitamin B 12 may administered to people with deficiency to prevent ischemic strokeTimepoint: 2 years

Countries

India

Contacts

Public ContactJane Betsy Isaac

Chettinad hospital and research institute

drvjshree@gmail.com9841455274

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026